This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Herantis Pharma Plc., Licentia, Ltd., Myneurocure Oy. Active years: 1999-2025.
Company Filing History:
2 out of 3 
1 out of 20 
1 out of 1 Years Active: 1999-2025
Title: Maria Lindahl: Innovator in Neurotrophic Factor Research
Introduction
Maria Lindahl is a prominent inventor based in Espoo, Finland. She has made significant contributions to the field of neuronal disorders through her innovative research and inventions. With a total of 5 patents, her work focuses on developing treatments for various neurological conditions.
Latest Patents
One of her latest patents is titled "Neurotrophic factor MANF and uses thereof." This invention relates to the treatment of neuronal disorders, specifically targeting conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction, and ischemic brain injury. The patent provides a pharmaceutical compound that includes a MANF nucleic acid molecule, MANF protein, or a functional fragment thereof, aimed at treating peripheral neuropathy.
Career Highlights
Throughout her career, Maria has worked with notable companies, including Herantis Pharma Plc. Her research has been instrumental in advancing the understanding and treatment of neuronal disorders.
Collaborations
Maria has collaborated with esteemed colleagues such as Mart Saarma and Merja Voutilainen, contributing to the collective knowledge in her field.
Conclusion
Maria Lindahl's innovative work in neurotrophic factors has the potential to significantly impact the treatment of various neurological disorders. Her contributions continue to pave the way for advancements in medical science.